Frank J Callaghan's Net Worth

$5.55 Million

Estimate Recalculated Sep 8, 2024 07:19PM EST

Who is Frank J Callaghan?

Frank J Callaghan has an estimated net worth of $5.55 Million. This is based on reported shares across multiple companies, which include ST JUDE MEDICAL INC, and ENDOCARDIAL SOLUTIONS INC.

SEC CIK

Frank J Callaghan's CIK is 0001172345

Past Insider Trading and Trends

2013 was Frank J Callaghan's most active year for acquiring shares with 14 total transactions. Frank J Callaghan's most active month to acquire stocks was the month of November. 2013 was Frank J Callaghan's most active year for disposing of shares, totalling 32 transactions. Frank J Callaghan's most active month to dispose stocks was the month of November. 2013 saw Frank J Callaghan paying a total of $8,529,697.54 for 240,181 shares, this is the most they've acquired in one year. In 2013 Frank J Callaghan cashed out on 482,752 shares for a total of $13,572,149.16, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ST JUDE MEDICAL INC No price found

President, CATD

Frank J Callaghan owns 4,514 units of Common Stock and 5,673 units of Common Sstock. In the year 2009 Frank J Callaghan acquired a total of 267,115 shares in ST JUDE MEDICAL INC at a cost of $9,299,897.54, Frank also disposed a total of 267,166 shares of ST JUDE MEDICAL INC equalling to $14,822,311.32.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+25.08%
905
$47.56
-$4,602,474.89
4.51K
Scheduled
Dec 14 - Dec 17
Form 4
-40.64%
-2.47K
$46.57
-$2,672,554.49
3.61K
Oct 21
Form 4
—
0
$52.96
-$22,990.00
22.35K
Scheduled
Aug 9
Form 4
-12.68%
-824.00
$51.54
-$42,470.53
5.67K
Jul 19
Form 4
—
0
$36.41
-$233,178.00
6.5K
Feb 7
Form 4
+97.18%
3.2K
$35.55
-$55,352.60
6.5K
Dec 14 - Dec 17
Form 4
—
0
—
—
0
Dec 10
Form 4
+102.81%
1.46K
$33.79
-$24,058.48
2.89K
Dec 14
Form 4
—
0
—
—
0
Dec 12
Form 4
-10.33%
-164.00
$35.17
-$5,767.88
1.42K
Dec 10
Form 4
—
0
$46.26
-$309,800.00
1.17K
May 3
Form 4
-53.23%
-1.33K
$40.60
-$54,160.40
1.17K
Feb 1
Form 4
—
0
—
—
0
Dec 14
Form 4
-6.14%
-164.00
$40.85
-$6,699.40
2.51K
Dec 10
Form 4
-11.18%
-336.00
$38.62
-$12,976.32
2.67K
Nov 8
Form 4
—
0
—
—
0
Dec 14
Form 4
-5.95%
-164.00
$37.90
-$6,215.60
2.59K
Dec 10
Form 4
—
0
—
—
0
Dec 15
Form 4
-6.52%
-164.00
$30.07
-$4,931.48
2.35K
Dec 10
Form 3
—
0
—
—
0
No matching records found

ENDOCARDIAL SOLUTIONS INC No price found

VP Research and Development

Frank J Callaghan owns 75 units of Common Stock. In the year 2004 Frank J Callaghan filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 20
Form 4
-97.39%
-2.80K
$10.42
-$29,171.00
75
Mar 8
No matching records found